Activation of PD-1 and PD-L1 signaling pathways can lead to the formation of immunosuppressive tumor microenvironment, while blocking PD-1/PD-L1 signaling pathway may reverse tumor immune microenvironment and enhance endogenous anti-tumor immune effect24,25. Here, CD274 is linked to neoplasm.